Cantor Fitzgerald Reiterates Overweight Rating on MannKind (MNKD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Wells Fargo raises oil price targets citing ongoing supply risks
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results
November 6, 2019 8:01 AM EST3Q 2019 Total Revenues of $14.6 million; +227% vs. 3Q 2018° 3Q 2019 Afrezza Net Revenue was $6.4 million; +46% vs. 3Q 2018    Afrezza sold to our marketing partner in Brazil for launch was $0.7 million°  3Q 2019 Collaborations and Services Revenue was $8.2 million Debt financing completed providing up to $75.0 million in non-dilutive capital Received second $12.5 million milestone payment from United Therapeutics in November 2019Advanced Technosphere® formulations of sumatriptan and tadalafil into nonclinical pharmacology studies... More
